Burning Rock Biotech Limi... (BNR)
6.55
0.09 (1.39%)
At close: Jan 13, 2025, 9:00 PM
6.50
-0.76%
After-hours Jan 14, 2025, 05:09 PM EST
undefined% (undefined)
| Bid | 6.5 |
| Market Cap | 72.39M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -5.67 |
| PE Ratio (ttm) | -1.16 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 7.4 |
| Volume | 28,628 |
| Avg. Volume (20D) | 20,436 |
| Open | 6.72 |
| Previous Close | 6.46 |
| Day's Range | 6.24 - 6.79 |
| 52-Week Range | 2.62 - 9.80 |
| Beta | undefined |
About BNR
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and prognosis prediction tests applicable to a range of cancer types, including lung cancer, gastrointestina...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Jun 12, 2020
Employees 786
Stock Exchange NASDAQ
Ticker Symbol BNR
Website https://www.brbiotech.com
1 month ago ·
Source
+13.61%
Burning Rock Biotech shares are trading higher aft...
Unlock content with
Pro Subscription
3 months ago ·
Source
-4.13%
Burning Rock Biotech shares are trading lower. The company announced the resignation of its director and CFO.
